Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cross Vetpharm Group, primarily operating under the brand name Bimeda, is a prominent global manufacturer and marketer of veterinary pharmaceuticals and animal health products. Founded in Ireland in 1960, the company has grown into a major international player with a presence in over 80 countries. Its extensive product portfolio covers a wide range of therapeutic areas, including parasiticides, anti-inflammatories, anti-infectives, and nutritional supplements for livestock, horses, and companion animals. The group operates numerous state-of-the-art manufacturing and R&D facilities across Europe, North America, South America, Africa, and Asia. Bimeda is particularly well-known for its leadership in the mastitis prevention market and its comprehensive range of cattle and sheep health products. As a privately-owned entity, the company focuses on long-term growth through both organic development and strategic acquisitions in the global animal health sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cross Vetpharm Group.